IL177227A - Compositions comprising zolpidem for delivering a hypnotic agent across the oral mucosa for treating insomnia - Google Patents

Compositions comprising zolpidem for delivering a hypnotic agent across the oral mucosa for treating insomnia

Info

Publication number
IL177227A
IL177227A IL177227A IL17722706A IL177227A IL 177227 A IL177227 A IL 177227A IL 177227 A IL177227 A IL 177227A IL 17722706 A IL17722706 A IL 17722706A IL 177227 A IL177227 A IL 177227A
Authority
IL
Israel
Prior art keywords
zolpidem
delivering
compositions
oral mucosa
treating insomnia
Prior art date
Application number
IL177227A
Other languages
Hebrew (he)
Other versions
IL177227A0 (en
Original Assignee
Transcept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transcept Pharmaceuticals Inc filed Critical Transcept Pharmaceuticals Inc
Publication of IL177227A0 publication Critical patent/IL177227A0/en
Publication of IL177227A publication Critical patent/IL177227A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL177227A 2004-02-17 2006-08-02 Compositions comprising zolpidem for delivering a hypnotic agent across the oral mucosa for treating insomnia IL177227A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78311804A 2004-02-17 2004-02-17
US59862904P 2004-08-03 2004-08-03
PCT/US2005/005021 WO2005079761A1 (en) 2004-02-17 2005-02-16 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof

Publications (2)

Publication Number Publication Date
IL177227A0 IL177227A0 (en) 2006-12-10
IL177227A true IL177227A (en) 2013-05-30

Family

ID=34890604

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177227A IL177227A (en) 2004-02-17 2006-08-02 Compositions comprising zolpidem for delivering a hypnotic agent across the oral mucosa for treating insomnia

Country Status (7)

Country Link
AU (1) AU2005215782B2 (en)
BR (1) BRPI0507733A (en)
CA (1) CA2556450C (en)
IL (1) IL177227A (en)
MX (1) MXPA06009296A (en)
NZ (1) NZ548856A (en)
WO (1) WO2005079761A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
KR20080031208A (en) * 2005-05-25 2008-04-08 트랜스셉트 파마슈티칼스, 인코포레이티드 Solid compositions and methods for treating middle-of-the night insomnia
EP2142183A2 (en) * 2007-04-09 2010-01-13 Sepracor Inc. Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders
FR2968992B1 (en) * 2010-12-16 2013-02-08 Sanofi Aventis ORODISPERSIBLE PHARMACEUTICAL TABLET BASED ON ZOLPIDEM
CN103919780B (en) * 2012-12-26 2016-12-28 上海中西制药有限公司 Calming soporific preparation, its compound preparation, preparation method and pharmaceutical composition
AU2019358394A1 (en) 2018-10-08 2021-05-06 Troikaa Pharmaceuticals Limited Oromucosal solutions of zolpidem or pharmaceutically acceptable salts thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005109A (en) * 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
TW370529B (en) * 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
US6624162B2 (en) * 2001-10-22 2003-09-23 Pfizer Inc. Imidazopyridine compounds as 5-HT4 receptor modulators

Also Published As

Publication number Publication date
AU2005215782A1 (en) 2005-09-01
CA2556450C (en) 2013-08-06
CA2556450A1 (en) 2005-09-01
NZ548856A (en) 2009-10-30
WO2005079761A1 (en) 2005-09-01
BRPI0507733A (en) 2007-07-10
AU2005215782B2 (en) 2011-04-21
MXPA06009296A (en) 2007-01-26
IL177227A0 (en) 2006-12-10

Similar Documents

Publication Publication Date Title
EP1715853A4 (en) Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
IL227117A (en) Insulin-containing pharmaceutical composition formulated for oral delivery
IL173742A0 (en) Compositions for delivering 5-ht agonists across the oral mucosa
IL181304A (en) Use of dihydropteridinones for the preparation of a pharmaceutical composition for treating myelodysplastic syndrome
EP1968554A4 (en) Bioadhesive drug formulations for oral transmucosal delivery
IL169480A0 (en) Pharmaceutical compositions comprising fentanyl for intranasal delivery
EP1750677A4 (en) Oral therapeutic compound delivery system
PL1973422T3 (en) Compositions providing a heating sensation for oral or dermal delivery
GB0427856D0 (en) Maniflod for use in medicament dispenser
EP1761250A4 (en) Oral delivery system
EP1809291A4 (en) Pharmaceutical compositions for transdermal delivery
IL216104A0 (en) Coated drug delivery formulations
LT2340872T (en) New pharmaceutical formulations useful in the treatment of insomnia
IL213897A0 (en) Ultrasound contrast agent dosage formulation
IL177227A (en) Compositions comprising zolpidem for delivering a hypnotic agent across the oral mucosa for treating insomnia
IL182999A0 (en) Transmucosal oral delivery device
GB0304636D0 (en) Pharmaceutical composition for nasal delivery
IL180316A0 (en) Quinolone-containing medicinal composition
GB0228305D0 (en) Therapeutic composition for respiratory delivery
HK1098059A1 (en) Composition comprising itraconazole for oral administration
ZA200607996B (en) Lozenge for delivery of dextromethorphan
ZA200606411B (en) Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
AU2003296961A8 (en) Targeted invitation delivery
HK1172830A1 (en) Ultrasound contrast agent dosage formulation
ZA200603126B (en) Pharmaceutical compositions for therapeutic use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees